Related Experiment Video

Updated: Apr 8, 2026

Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype
14:51

Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype

Published on: June 17, 2022

3.7K

Multimodal gene and targeted drug therapy for chronic myelogenous leukemia using BIM/MCL-1 chimeric nanoparticle:

Margaret L Lugin1, Winnie Lei2,3,4, Rebecca T Lee5

  • 1Department of Chemical and Biomolecular Engineering, University of California, Irvine, CA, 92697, USA.

Nano Convergence
|April 7, 2026
PubMed
Abstract

No abstract available in PubMed .

Keywords:
Chronic myeloid leukemiaCombined gene and targeted therapyDasatinibMulti- omics network analysisSimultaneous BIM expression and MCL-1 silencingSynergized apoptosisViral/nonviral chimeric nanoparticles

More Related Videos

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence
10:09

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence

Published on: January 7, 2019

8.9K
Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice
08:57

Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice

Published on: October 5, 2017

11.6K

Related Experiment Videos

Last Updated: Apr 8, 2026

Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype
14:51

Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype

Published on: June 17, 2022

3.7K
Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence
10:09

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence

Published on: January 7, 2019

8.9K
Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice
08:57

Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice

Published on: October 5, 2017

11.6K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

9.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

6.4K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.4K

Articles linked to this work by shared authors, journal, and citation graph.

Beyond triple-negative: germline MPL and SH2B3/LNK mutations reshape the genetic landscape of hereditary thrombocytosis.

Haematologica·2026

Sapablursen for Erythrocytosis Control in Patients with Polycythemia Vera.

Blood·2026

CRISPRi-Mediated Epigenetic Suppression of TERT Reduces Cell Growth in Non-Small-Cell Lung Cancer Cells.

Cells·2026

A systems-level machine learning approach uncovers therapeutic targets in clear cell renal cell carcinoma.

npj drug discovery·2026

Streamlined synthetic regulatory cassette for efficient and photoreceptor-enriched retinal gene expression.

Molecular therapy. Nucleic acids·2026

Real-world evidence for the impact of circadian clock on the benefit from immune checkpoint inhibitors in solid tumors.

BMC cancer·2026

Dehydration-resistant multi-functional hydrogel-based iontophoretic drug delivery for wound healing.

Nano convergence·2026

In-line fiber-integrated photon-pair generation from van der Waals crystals.

Nano convergence·2026

Damage-free van der Waals metal/NbOx-NbSe2 integration for reliable and flexible memristor in neuromorphic computing.

Nano convergence·2026

Clinical OCT computation-modeled prognosis of coronary plaque progression with validation by fusogenic macrophage nano-targeting.

Nano convergence·2026

Submicron traction-force mapping reveals mitochondrial regulation of nanoscale force coordination during rigidity sensing under oxidative stress.

Nano convergence·2026

Programmable nanomedicine via bioorthogonal molecular engineering.

Nano convergence·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us